Organon Pharma Indonesia Tbk. vs Shield On Service Tbk. — how do they compare? Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B), while Shield On Service Tbk. trades at Rp945 (market cap 920.93B, 100 24h volume). The key difference: Shield On Service Tbk. is far larger — about 8.8× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| SCPI | SOSS | |
|---|---|---|
Market Cap | 104.4B | 920.93B |
Volume | — | 100 |
Lot | — | 1 |
Turnover | — | 94.5K |
Average Price | — | 945 |
Value | — | 94.5K |
Indicative Equilibrium Price | — | 1,010 |
Indicative Equilibrium Volume | — | 2K |
Trailing returns across standard periods
Latest headlines on both assets
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →PT Shield On Service Tbk (the Company), was established on August 5, 2004 based on Notarial Deed No. 6 of Veronica Lily Dharma, S.H.
Read more on SOSS →